Trial Profile
Post Marketing Surveillance on Safety and Effectiveness Evaluation of INVOSSA K Inj.
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 13 Jul 2023
Price :
$35
*
At a glance
- Drugs Tonogenchoncel-L (Primary)
- Indications Osteoarthritis
- Focus Adverse reactions
- Sponsors Kolon Life Science
- 24 May 2019 Status changed from recruiting to active, no longer recruiting.
- 31 Jan 2018 New trial record